Alucent Biomedical, Inc. — Form D

Alucent Biomedical, Inc. of SALT LAKE CITY, UT, a company, filed a Form D exempt-offering notice with the SEC on 2020-10-15. The offering totals $35.0M, of which $35.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (28)

Showing 25 of 28 people.

NameRoleLocation
James D CorbettDirectorSalt Lake City, UT
Pat D CostelloDirectorSalt Lake City, UT
David N FlicekDirectorSalt Lake City, UT
Myles D GreenbergDirectorSalt Lake City, UT
Ryan D HansenDirectorSalt Lake City, UT
Julie N LauttDirectorSalt Lake City, UT
Dan D PelakDirectorSalt Lake City, UT
Myles D GreenbergExecutive OfficerSalt Lake City, UT
Scott N MayfieldExecutive OfficerSalt Lake City, UT
Daniel PelakDirectorAliso Viejo, CA
Julie LauttDirectorSalt Lake City, UT
James CorbettDirectorSalt Lake City, UT
Bruce KrattenmakerExecutive OfficerSalt Lake City, UT
Kevin WarnerExecutive OfficerSalt Lake City, UT
Colin JacksonExecutive OfficerSalt Lake City, UT
Myles GreenbergDirectorSalt Lake City, UT
Myles GreenbergExecutive OfficerSalt Lake City, UT
David FlicekDirectorSalt Lake City, UT
Katalin KauserExecutive OfficerSalt Lake City, UT
Nick PappasDirectorSalt Lake City, UT
James IsaacsonExecutive OfficerSalt Lake City, UT
Henry HauserExecutive OfficerSalt Lake City, UT
Michael ElliotDirectorAustin, TX
Julie NortonDirectorSioux Falls, SD
David KapaskaDirectorSioux Falls, SD

Other filings by this issuer (2)

FiledFormOfferingSold
2023-04-20D$11.2M$11.2M
2015-01-27D$400K$400K

More